pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health131
viewlistcards
  • VONJO
    VONJO (PACRITINIB CITRATE)
    no indication Sobi Inc
  • VOQUEZNA
    VOQUEZNA (VONOPRAZAN FUMARATE)
    1 INDICATIONS AND USAGE VOQUEZNA TRIPLE PAK, is a co-pack…$PHAT Phathom Pharmaceuticals, Inc.
  • VOQUEZNA DUAL PAK
    VOQUEZNA DUAL PAK (AMOXICILLIN)
    1 INDICATIONS AND USAGE VOQUEZNA TRIPLE PAK, is a co-pack…$PHAT Phathom Pharmaceuticals, Inc.
  • VOQUEZNA TRIPLE PAK
    VOQUEZNA TRIPLE PAK (AMOXICILLIN)
    1 INDICATIONS AND USAGE VOQUEZNA TRIPLE PAK, is a co-pack…
← prev
page 173 of 271
next →
Pain89
Neurology1
$PHAT Phathom Pharmaceuticals, Inc.
  • VOYXACT
    VOYXACT (SIBEPRENLIMAB-SZSI)
    no indication Otsuka Pharmaceutical Co Ltd
  • Phase 2
    VP-001
    Retinitis Pigmentosa (Retinitis) PYC Therapeutics Ltd
  • Preclinical
    VPD-380
    Pulmonary Arterial Hypertension Corsair Pharma Inc
  • Phase 2
    VR-101
    Female Contraception VaRi Bioscience GmbH
  • Phase 2
    VR-103
    Endometriosis VaRi Bioscience GmbH
  • VRAYLAR
    VRAYLAR (CARIPRAZINE HYDROCHLORIDE)
    1 . INDICATIONS AND USAGE VRAYLAR ® is indicated for: • T…$ABBV AbbVie Inc.
  • Preclinical
    VRG-145
    Migraine VRG Therapeutics Ltd
  • Preclinical
    VS-01
    Hyperammonemia Genfit SA
  • Phase 1
    VS-041
    Diastolic Heart Failure (HFpEF) Vasa Therapeutics SP Zoo
  • Phase 1
    VS-105
    Secondary Hyperparathyroidism Vidasym Inc
  • Phase 2
    VT-3989
    Malignant Pleural Mesothelioma Vivace Therapeutics Inc
  • Phase 1
    VT-A
    Pulmonary Arterial Hypertension VasThera Co Ltd
  • Preclinical
    VTA-100
    Limb-Girdle Muscular Dystrophy Vita Therapeutics Inc
  • Preclinical
    VTI-1002
    Bullous Pemphigoid viDA Therapeutics Inc
  • Phase 1
    VTP-1000
    Celiac Disease$BRNS Barinthus Biotherapeutics plc.
  • Phase 2
    VTR-297
    Onychomycosis (Tinea Unguium)$VNDA Vanda Pharmaceuticals Inc.
  • Preclinical
    VTRU-200
    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Vitruviae LLC
  • Preclinical
    VTX-803
    Progressive Familial Intrahepatic Cholestasis Vivet Therapeutics SAS
  • Preclinical
    VTX-806
    Cerebrotendinous Xanthomatosis Vivet Therapeutics SAS
  • Phase 2
    VTx-002
    Amyotrophic Lateral Sclerosis VectorY Therapeutics Inc
  • VUSION
    VUSION (MICONAZOLE NITRATE, ZINC OXIDE, WHITE PETROLATUM)
    no indication MYLAN
  • Preclinical
    VV-169
    Refractory Multiple Myeloma$NVS NOVARTIS AG
  • Preclinical
    VV-2003
    Enterocolitis Vivreon Biosciences LLC
  • Preclinical
    VV-8325
    Alzheimer's Disease Vivreon Biosciences LLC
  • Phase 1
    VVD-037
    Solid Tumor Vividion Therapeutics Inc
  • Phase 1
    VVD-850
    Non-Small Cell Lung Cancer Vividion Therapeutics Inc